CSLLY News and Press, CSL Ltd. ADR

CSL announces expansion of Illinois plasma therapy manufacturing facility PR Newswire New $1.5 billion investment builds on over $3 billion already spent on CSL's U.S. operations since 2018 Expansion will create at least 300 new jobs and enhance production of plasma-derived therapi...

Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract Canada NewsWire CSL Seqirus will supply millions of doses of adjuvanted cell-based vaccine to support Canadians, in the event the World Health Organization (WHO) declares an ...

2026-02-17 17:00:50 ET More on Eli Lilly Eli Lilly: Positives Outweigh The Concerns Eli Lilly and Company 2025 Q4 - Results - Earnings Call Presentation Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript Eli Lilly posts late-stage trial win for Rete...

2026-02-10 22:24:20 ET CSL Limited (CSLLY) Q2 2026 Earnings Call February 10, 2026 6:00 PM EST Company Participants Mark Dehring Gordon Naylor Ken Lim - Chief Financial Officer Andy Schmeltz - Chief Commercial Officer Dave Ross - Senior VP & GM of S...

2026-02-10 06:14:33 ET CSL Limited (CSLLY) Discusses Leadership Transition and Appointment of Interim CEO February 10, 2026 1:00 AM EST... Read the full article on Seeking Alpha For further details see: CSL Limited (CSLLY) Discusses Leadership Transition and Appointment of I...

2026-01-28 06:01:24 ET CSL Limited ( CMXHF ) ( CSLLY ) (CSL.AX) recently crossed my watchlist because the share is trading at a P/E ratio lower than at any point in the last 10 years, while revenue and profits are growing.... Read the full article on Seeking Alpha For fu...

Deutsche Bank announced today its appointment as successor depositary bank for the sponsored American Depositary Receipt program of CSL Limited. CSL Limited (OTC: CSLLY) is a global biopharma company with a dynamic portfolio of medicines. CSL uses its expertise in plasma-derived therapies, va...

2026-01-26 10:55:32 ET More on Moderna, Pfizer Pfizer: Expect Another Double Beating For Q1 (Earnings Preview) Pfizer: Rebound Has Just Started Pfizer: The Most Intriguing Value Play Of 2026 Notable healthcare headlines for the week: J&J, Moderna, Bristol...

2026-01-08 07:20:06 ET More on Gilead Sciences, CVS , etc. Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript Roche Holding AG (RHHBY) Shareholder/Analyst Call - Slideshow CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript ...

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years PR Newswire - 94% of patients (51 of 54) remained free from the burden of continuous prophylaxis treatment through fiv...